Citigroup
TXG icon

Citigroup’s 10x Genomics TXG Stock Holding History

Citigroup’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-21,200
Closed -$773K – 5866
2022
Q4 		$773K Buy
+21,200
New +$693K ﹤0.01% 2855
2022
Q3 		– Sell
-120,200
Closed -$5.44M – 6332
2022
Q2 		$5.44M Buy
120,200
+58,600
+95% +$3.04M ﹤0.01% 1489
2022
Q1 		$4.69M Buy
61,600
+34,600
+128% +$3.03M ﹤0.01% 1709
2021
Q4 		$4.02M Buy
+27,000
New +$4.14M ﹤0.01% 2008

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup's TXG Position: Q2 2026 in Review

Citigroup increased its 10x Genomics (TXG) stake by 34% in Q2 2026, buying an estimated $443K and bringing the position to 67,385 shares worth $2.58M. The position accounts for ﹤0.01% of the portfolio, ranked #2736.

Citigroup first reported a position in TXG in Q4 2019 and has held it in 27 quarters since. The position peaked at $18.1M in Q2 2021. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Citigroup held 67,385 shares of 10x Genomics worth $2.58M as of Q2 2026.
  • Citigroup bought 16,910 10x Genomics shares in Q2 2026, an estimated $443K.
  • 10x Genomics made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #2736 holding.
  • Citigroup first reported a position in 10x Genomics in Q4 2019 and has held it in 27 quarters since.
  • Citigroup's 10x Genomics position peaked at $18.1M in Q2 2021.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.